![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication January 31, 2005.
Revised June 3, 2005.
Accepted for publication June 6, 2005.
Transient receptor potential vanilloid 1 (TRPV1) is a capsaicin- and heat-gated ion channel required for normal in vivo responses to these painful stimuli. However growing evidence suggests that TRPV1 also participates in thermoregulation. We therefore examined the effects of a selective TRPV1 antagonist, 5-Iodoresiniferatoxin (I-RTX), on mouse body temperature. Surprisingly, subcutaneous administration of I-RTX (0.1 - 1 µmol/kg) evoked a hypothermic response similar to that evoked by capsaicin (9.8 µmol/kg) in naïve wild-type mice, but not in mice pretreated with resiniferatoxin, a potent TRPV1 agonist, or in naïve TRPV1 null mice. In response to I-RTX in vitro, HEK293 cells expressing rat TRPV1 exhibited increases in intracellular Ca2+ (biphasic, EC50 = 56.7 nM and 9.9 µM) that depended on Ca2+ influx and outwardly rectifying, capsazepine-sensitive, currents that were smaller than those evoked by 1 µM capsaicin. Thus, I-RTX induces TRPV1-dependent hypothermia in vivo and is a partial TRPV1 agonist in vitro.
Key words:
TRPV1, capsaicin, iodoresiniferatoxin, resiniferatoxin, thermoregulation, vanilloid
This article has been cited by other articles:
![]() |
A. Bhattacharya, B. P. Scott, N. Nasser, H. Ao, M. P. Maher, A. E. Dubin, D. M. Swanson, N. P. Shankley, A. D. Wickenden, and S. R. Chaplan Pharmacology and Antitussive Efficacy of 4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic Acid (5-Trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a Transient Receptor Potential Vanilloid 1 Antagonist in Guinea Pigs J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 665 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Steiner, V. F. Turek, M. C. Almeida, J. J. Burmeister, D. L. Oliveira, J. L. Roberts, A. W. Bannon, M. H. Norman, J.-C. Louis, J. J. S. Treanor, et al. Nonthermal Activation of Transient Receptor Potential Vanilloid-1 Channels in Abdominal Viscera Tonically Inhibits Autonomic Cold-Defense Effectors J. Neurosci., July 11, 2007; 27(28): 7459 - 7468. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Johnson, E. M. Garrett, R. Rutter, T. P. Bonnert, Y.-D. Gao, R. E. Middleton, and K. G. Sutton Functional Mapping of the Transient Receptor Potential Vanilloid 1 Intracellular Binding Site Mol. Pharmacol., September 1, 2006; 70(3): 1005 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lazar, D. C. Braun, A. Toth, Y. Wang, L. V. Pearce, V. A. Pavlyukovets, P. M. Blumberg, S. H. Garfield, S. Wincovitch, H.-K. Choi, et al. Kinetics of Penetration Influence the Apparent Potency of Vanilloids on TRPV1 Mol. Pharmacol., April 1, 2006; 69(4): 1166 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Gavva, R. Tamir, L. Klionsky, M. H. Norman, J.-C. Louis, K. D. Wild, and J. J. S. Treanor Proton Activation Does Not Alter Antagonist Interaction with the Capsaicin-Binding Pocket of TRPV1 Mol. Pharmacol., December 1, 2005; 68(6): 1524 - 1533. [Abstract] [Full Text] [PDF] |
||||